Subsequent anti-myeloma therapy after idecabtagene vicleucel treatment in patients with relapsed/refractory multiple myeloma: A single center analysis

Ricardo D. Parrondo, Keren Sam, Ahsan Rasheed, Victoria Alegria, Taimur Sher, Vivek Roy, Asher Chanan-Khan, Sikander Ailawadhi

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Article number66
JournalBlood cancer journal
Issue number4
StatePublished - Apr 2022

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this